Skip to main content

Table 2 Baseline characteristics of the population who received treatment for CAD

From: The clinical value and cost-effectiveness of treatments for patients with coronary artery disease

 

OMT (n = 19,467)

95% CI

PCI (n = 3205)

95% CI

CABG (n = 1102)

95% CI

Age, mean

62.96

62.80–63.12

58.85

58.47–59.23

60.84

60.30–61.39

Male

13,521 (69%)

13,294–13,751

2,650 (83%)

2550–2753

911 (83%)

853–972

Female

5,913 (30%)

5763–6066

546 (17%)

501–594

189 (17%)

163–218

Chinese

13,853 (71%)

13,623–14,086

2005 (63%)

1918–2095

712 (65%)

661–766

Malay

2,266 (12%)

2173–2361

475 (15%)

433–520

161 (15%)

137–188

Indian

2,498 (13%)

2401–2598

424 (13%)

385–466

115 (10%)

95–138

Others

850 (4%)

794–909

301 (9%)

268–337

114 (10%)

94–137

Diag LM

255 (1%)

225–288

67 (2%)

52–85

22 (2%)

14–33

Diag TVD

3,780 (19%)

3660–3902

588 (18%)

438–525

480 (44%)

438–525

LM & TVD

1,935 (10%)

1850–2023

143 (4%)

431–518

473 (43%)

431–518

Diabetes

8,453 (43%)

8274–8635

1185 (37%)

1119–1254

504 (46%)

461–550

Hypertension

14,456 (74%)

14,221–14,694

2157 (67%)

2067–2250

838 (76%)

782–897

Dyslipidemia

15,251 (78%)

15,010–15,495

2430 (76%)

2334–2529

911 (83%)

853–972

LVEF ≤ 40%

3,290 (17%)

3179–3404

441 (14%)

401–484

215 (20%)

187–246

  1. Notes: LVEF ≤ 40% = left ventricular dysfunction; TVD = triple vessel disease